• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter re: Prognosis, clinicopathological characteristics, and treatment patterns of patients with ER-intermediate-positive breast cancer undergoing long-term follow-up.

作者信息

Güzel H G, Önder A H

机构信息

Department of Medical Oncology, Antalya Training and Research Hospital, Antalya, Turkey.

Department of Medical Oncology, Antalya Training and Research Hospital, Antalya, Turkey.

出版信息

ESMO Open. 2025 May;10(5):105111. doi: 10.1016/j.esmoop.2025.105111. Epub 2025 Apr 30.

DOI:10.1016/j.esmoop.2025.105111
PMID:40311182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12084390/
Abstract
摘要

相似文献

1
Letter re: Prognosis, clinicopathological characteristics, and treatment patterns of patients with ER-intermediate-positive breast cancer undergoing long-term follow-up.关于接受长期随访的雌激素受体中等阳性乳腺癌患者的预后、临床病理特征及治疗模式的信函。
ESMO Open. 2025 May;10(5):105111. doi: 10.1016/j.esmoop.2025.105111. Epub 2025 Apr 30.
2
Prognosis, clinicopathological characteristics, and treatment patterns of patients with ER-intermediate-positive breast cancer undergoing long-term follow-up.接受长期随访的雌激素受体中度阳性乳腺癌患者的预后、临床病理特征及治疗模式
ESMO Open. 2025 Apr;10(4):104508. doi: 10.1016/j.esmoop.2025.104508. Epub 2025 Mar 31.
3
Prevalence, treatment patterns, and prognosis of low estrogen receptor-positive (1% to 10%) breast cancer: a single institution's experience in Korea.韩国单机构经验：低雌激素受体阳性（1%~10%）乳腺癌的流行情况、治疗模式和预后。
Breast Cancer Res Treat. 2021 Oct;189(3):653-663. doi: 10.1007/s10549-021-06309-1. Epub 2021 Sep 6.
4
[Clinicopathological features and prognosis of synchronous bilateral breast cancers].[同步性双侧乳腺癌的临床病理特征及预后]
Zhonghua Bing Li Xue Za Zhi. 2020 May 8;49(5):435-440. doi: 10.3760/cma.j.cn112151-20191224-00825.
5
Influence of progesterone receptor on metastasis and prognosis in breast cancer patients with negative HER-2.孕激素受体对HER-2阴性乳腺癌患者转移及预后的影响
Gland Surg. 2022 Jan;11(1):77-90. doi: 10.21037/gs-21-677.
6
Clinicopathological Features and Survival for Low ER-positive Breast-cancer Patients.低雌激素受体阳性乳腺癌患者的临床病理特征和生存情况。
Altern Ther Health Med. 2022 Sep;28(6):36-41.
7
Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.单一激素受体阳性乳腺癌患者的临床病理特征和乳腺癌特异性生存分析。
JAMA Netw Open. 2020 Jan 3;3(1):e1918160. doi: 10.1001/jamanetworkopen.2019.18160.
8
Borderline ER-Positive Primary Breast Cancer Gains No Significant Survival Benefit From Endocrine Therapy: A Systematic Review and Meta-Analysis.交界性 ER 阳性原发性乳腺癌从内分泌治疗中获益不明显：系统评价和荟萃分析。
Clin Breast Cancer. 2018 Feb;18(1):1-8. doi: 10.1016/j.clbc.2017.06.005. Epub 2017 Jun 23.
9
High expression of progesterone receptor may be an adverse prognostic factor in oestrogen receptor-negative/progesterone receptor-positive breast cancer: results of comprehensive re-evaluation of multi-institutional case series.孕激素受体高表达可能是雌激素受体阴性/孕激素受体阳性乳腺癌的不良预后因素：多机构病例系列综合再评估结果。
Pathology. 2022 Apr;54(3):269-278. doi: 10.1016/j.pathol.2021.10.003. Epub 2022 Jan 21.
10
Prognosis and influencing factors of ER-positive, HER2-low breast cancer patients with residual disease after neoadjuvant chemotherapy: a retrospective study.新辅助化疗后残留病灶仍为 ER 阳性、HER2 低表达的乳腺癌患者的预后及其影响因素：一项回顾性研究。
Sci Rep. 2024 May 23;14(1):11761. doi: 10.1038/s41598-024-62592-0.

本文引用的文献

1
Prognosis, clinicopathological characteristics, and treatment patterns of patients with ER-intermediate-positive breast cancer undergoing long-term follow-up.接受长期随访的雌激素受体中度阳性乳腺癌患者的预后、临床病理特征及治疗模式
ESMO Open. 2025 Apr;10(4):104508. doi: 10.1016/j.esmoop.2025.104508. Epub 2025 Mar 31.
2
Prognostic significance of ER-to-PR difference in ER+/HER2- early breast cancer.ER+/HER2- 早期乳腺癌中 ER 到 PR 的差异的预后意义。
Sci Rep. 2024 Oct 18;14(1):24431. doi: 10.1038/s41598-024-74608-w.
3
High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.高Ki-67表达和低孕激素受体表达可独立导致雌激素受体阳性且人表皮生长因子受体2阴性的绝经后乳腺癌患者预后较差。
Clin Breast Cancer. 2015 Jun;15(3):204-11. doi: 10.1016/j.clbc.2014.12.007. Epub 2014 Dec 24.
4
Which threshold for ER positivity? a retrospective study based on 9639 patients.雌激素受体阳性的阈值是多少？一项基于9639例患者的回顾性研究。
Ann Oncol. 2014 May;25(5):1004-11. doi: 10.1093/annonc/mdu053. Epub 2014 Feb 20.
5
Ki67 and proliferation in breast cancer.Ki67 与乳腺癌增殖。
J Clin Pathol. 2013 Jun;66(6):512-6. doi: 10.1136/jclinpath-2012-201085. Epub 2013 Feb 22.